Literature DB >> 26018810

White Matter Degeneration in Atypical Alzheimer Disease.

Francesca Caso1, Federica Agosta1, Daniele Mattavelli1, Raffaella Migliaccio1, Elisa Canu1, Giuseppe Magnani1, Alessandra Marcone1, Massimiliano Copetti1, Monica Falautano1, Giancarlo Comi1, Andrea Falini1, Massimo Filippi1.   

Abstract

PURPOSE: To assess white matter (WM) tract damage in patients with atypical Alzheimer disease (AD), including early-onset AD (EOAD), logopenic variant of primary progressive aphasia (lvPPA), and posterior cortical atrophy (PCA), by using diffusion-tensor magnetic resonance (MR) imaging and to identify similarities and differences across the AD spectrum.
MATERIALS AND METHODS: This study was approved by the local ethical committees on human studies, and written informed consent from all subjects was obtained prior to enrollment. WM tract damage and cortical atrophy were assessed by using diffusion-tensor MR imaging and voxel-based morphometry, respectively, in 28 patients with EOAD, 12 patients with lvPPA, and 13 patients with PCA relative to age- and sex-matched healthy subjects. Conjunction and interaction analyses were used to define overlapping and syndrome-specific patterns of brain damage.
RESULTS: Patients with EOAD, lvPPA, and PCA shared a common pattern of WM damage that involved the body of the corpus callosum, fornix, and main anterior-posterior pathways (P < .05). They also shared cortical atrophy of the left temporoparietal regions and precuneus (P < .05, family-wise error corrected). Patients with EOAD also had specific damage to the genu and splenium of the corpus callosum and parahippocampal tract bilaterally (P < .05). In all patients with AD, particularly in the two focal forms (lvPPA and PCA), WM damage was more severe and widely distributed than expected on the basis of cortical atrophy.
CONCLUSION: In atypical AD clinical phenotypes, the distribution of WM damage exceeds cortical atrophy and may reflect the pathologic dissemination through structural connections from atrophic to unaffected cortical regions. WM degeneration may be an early marker of AD pathologic changes in EOAD and focal AD forms. (©) RSNA, 2015 Online supplemental material is available for this article.

Entities:  

Mesh:

Year:  2015        PMID: 26018810     DOI: 10.1148/radiol.2015142766

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  17 in total

1.  Dysfunctional white-matter networks in medicated and unmedicated benign epilepsy with centrotemporal spikes.

Authors:  Yuchao Jiang; Li Song; Xuan Li; Yaodan Zhang; Yan Chen; Sisi Jiang; Changyue Hou; Dezhong Yao; Xiaoming Wang; Cheng Luo
Journal:  Hum Brain Mapp       Date:  2019-04-01       Impact factor: 5.038

2.  Regional multimodal relationships between tau, hypometabolism, atrophy, and fractional anisotropy in atypical Alzheimer's disease.

Authors:  Irene Sintini; Christopher G Schwarz; Peter R Martin; Jonathan Graff-Radford; Mary M Machulda; Matthew L Senjem; Robert I Reid; Anthony J Spychalla; Daniel A Drubach; Val J Lowe; Clifford R Jack; Keith A Josephs; Jennifer L Whitwell
Journal:  Hum Brain Mapp       Date:  2018-12-13       Impact factor: 5.038

Review 3.  Early-Onset Alzheimer Disease.

Authors:  Mario F Mendez
Journal:  Neurol Clin       Date:  2017-05       Impact factor: 3.806

Review 4.  Dissecting the complexities of Alzheimer disease with in vitro models of the human brain.

Authors:  Joel W Blanchard; Matheus B Victor; Li-Huei Tsai
Journal:  Nat Rev Neurol       Date:  2021-11-08       Impact factor: 42.937

5.  Maternal dementia age at onset in relation to amyloid burden in non-demented elderly offspring.

Authors:  Jacqueline E Maye; Rebecca A Betensky; Christopher M Gidicsin; Joseph Locascio; J Alex Becker; Lesley Pepin; Jeremy Carmasin; Dorene M Rentz; Gad A Marshall; Deborah Blacker; Reisa A Sperling; Keith A Johnson
Journal:  Neurobiol Aging       Date:  2015-12-28       Impact factor: 4.673

6.  Single-cell transcriptomic analysis of Alzheimer's disease.

Authors:  Hansruedi Mathys; Jose Davila-Velderrain; Zhuyu Peng; Fan Gao; Shahin Mohammadi; Jennie Z Young; Madhvi Menon; Liang He; Fatema Abdurrob; Xueqiao Jiang; Anthony J Martorell; Richard M Ransohoff; Brian P Hafler; David A Bennett; Manolis Kellis; Li-Huei Tsai
Journal:  Nature       Date:  2019-05-01       Impact factor: 49.962

7.  Increased White Matter Inflammation in Aging- and Alzheimer's Disease Brain.

Authors:  Divya Raj; Zhuoran Yin; Marjolein Breur; Janine Doorduin; Inge R Holtman; Marta Olah; Ietje J Mantingh-Otter; Debby Van Dam; Peter P De Deyn; Wilfred den Dunnen; Bart J L Eggen; Sandra Amor; Erik Boddeke
Journal:  Front Mol Neurosci       Date:  2017-06-30       Impact factor: 5.639

8.  Profiling heterogeneity of Alzheimer's disease using white-matter impairment factors.

Authors:  Xiuchao Sui; Jagath C Rajapakse
Journal:  Neuroimage Clin       Date:  2018-10-29       Impact factor: 4.881

9.  ApoE influences regional white-matter axonal density loss in Alzheimer's disease.

Authors:  Catherine F Slattery; Jiaying Zhang; Ross W Paterson; Alexander J M Foulkes; Amelia Carton; Kirsty Macpherson; Laura Mancini; David L Thomas; Marc Modat; Nicolas Toussaint; David M Cash; John S Thornton; Susie M D Henley; Sebastian J Crutch; Daniel C Alexander; Sebastien Ourselin; Nick C Fox; Hui Zhang; Jonathan M Schott
Journal:  Neurobiol Aging       Date:  2017-05-03       Impact factor: 4.673

10.  Functional and structural brain networks in posterior cortical atrophy: A two-centre multiparametric MRI study.

Authors:  Federica Agosta; Gorana Mandic-Stojmenovic; Elisa Canu; Tanja Stojkovic; Francesca Imperiale; Francesca Caso; Elka Stefanova; Massimiliano Copetti; Vladimir S Kostic; Massimo Filippi
Journal:  Neuroimage Clin       Date:  2018-06-12       Impact factor: 4.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.